Immunogenicity，Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 Vaccine

NCT05329038 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Inactivated COVID-19 Vaccine

Sponsor

Sinovac Life Sciences Co., Ltd.